Beta-blockers for LQT3: Contraindicated, acceptable or the drug of choice?

20 June 2017 (09:15 - 09:37)
Organised by:
Congress Presentation Part of: Medical treatment of channelopathies: effective and safe? Pharmacology EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017